PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/
Fund Intelligence

VC Fund Dossiers

1980 funds indexed — verified founder intel only

1980
Funds
Verified
Access
0 allowed
Investors
30 of 1980 fundsClear Filters
Status
Fund Name
HQ
Stage Focus
Truth Cards
AI INTEL
5AM Ventures
San Francisco, CA
Series A
0No verified founder data yet
BERNIE'S TAKE

5AM is one of the smarter life sciences funds that actually gets the tech side of biotech. They're not just former Big Pharma folks writing checks — they understand computational platforms and can help you navigate both the science and the business. The partners are genuinely helpful post-investment and have solid pharma connections for partnerships. However, they're picky as hell and move slower than software VCs, so don't expect quick decisions. They also tend to want meaningful board seats and operational input, which is great if you want the help but can feel heavy-handed if you don't.

AI INTEL
Aberdare Ventures
San Francisco, CA
Series A
0No verified founder data yet
BERNIE'S TAKE

Aberdare is healthcare VC royalty that's gone quiet. Paul Klingenstein has an enviable 25-year track record of picking billion-dollar winners like Omada, Nevro, and Castlight, but the fund has basically been sleepwalking since 2021 - their last investment was September 2021. They're the definition of old-school healthcare investors who understand the sector deeply but seem to have missed the AI/digital health wave that younger funds are riding. When they do invest, they write meaningful checks ($8M sweet spot) and actually know what they're doing, but good luck getting their attention right now. The Mohit Kaushal departure in 2014 left them without their digital health champion, and it shows.

AI INTEL
Adjuvant Capital
New York, NY
Series A
0No verified founder data yet
BERNIE'S TAKE

Adjuvant Capital is what happens when the Gates Foundation alumni club decides to prove that doing good and making money aren't mutually exclusive in global health. Glenn Rockman and Jenny Yip are seasoned operators with serious pedigree - Rockman helped launch the $108M Global Health Investment Fund, and Yip ran strategic investments at Gates Foundation. They've attracted heavyweight LPs including Gates ($75M anchor), Novartis, Merck, and have already delivered exits with acquisitions of AN2 Therapeutics and others. They're not just writing checks - every investment comes with 'Global Access Commitments' to ensure products reach underserved populations, which is either admirable mission alignment or clever marketing to impact investors. The real test isn't their do-gooder credentials - it's whether they can generate actual returns while staying true to their access mission when the rubber meets the road.

AI INTEL
Ally Bridge Group
New York, NY
Series A
0No verified founder data yet
BERNIE'S TAKE

Ally Bridge is essentially a cross-border specialist that made their name in the biotech boom, with some impressive exits like their early Moderna stake. They're genuinely well-connected in both US and Chinese markets, which is valuable if you need Asia-Pacific partnerships or expansion. However, they're pretty narrow in focus - if you're not in healthcare or don't have a clear Asia angle, you're probably not their cup of tea. They tend to be hands-on with portfolio companies, which some founders love and others find intrusive. The China connection is both their superpower and potential liability depending on current geopolitical winds.

AI INTEL
Amplitude Venture Capital
Montreal, QC
Series A
0No verified founder data yet
BERNIE'S TAKE

Amplitude is a solid regional player that's punching above its weight class, especially if you're Canadian or selling into the Quebec market. They're operationally savvy and won't waste your time with fluffy advice - expect real, actionable feedback. The downside? Limited brand recognition outside Canada can hurt with customer acquisition and follow-on rounds from top-tier US funds. They're genuinely helpful post-investment but don't expect them to open doors at Google or Microsoft the way a Sequoia would.

AI INTEL
Arboretum Ventures
Ann Arbor, MI
Series A
0No verified founder data yet
BERNIE'S TAKE

Arboretum is a solid, if unspectacular, healthcare-focused fund that actually knows the space rather than just chasing healthcare as a hot sector. Tim Petersen and team have real operational chops and will roll up their sleeves to help with business development and strategic partnerships. The Michigan connection is real — they leverage University of Michigan resources and can help with talent and clinical partnerships. However, their check sizes are modest and they expect founders to be very metrics-driven from day one. Not the fund for moonshot science projects, but great for founders who want engaged partners who understand healthcare's unique challenges.

AI INTEL
Claritas Capital
Nashville, TN
Series A
0No verified founder data yet
BERNIE'S TAKE

Claritas is the rare fund that actually walks the walk on operational value-add - they'll dig deep into your metrics and push you on unit economics in ways that can be genuinely helpful or mildly annoying depending on your style. They're not chasing the hottest deals in Silicon Valley, which means they actually have time to work with their companies, but also means their brand won't open as many doors on the coasts. The Southeast focus is real - they understand these markets better than most coastal funds, but if you're building something that needs to be in SF or NYC, they might not be your best bet. They're known for being disciplined on valuation and won't get into bidding wars, which founders either love or hate depending on their fundraising timeline.

AI INTEL
Frazier Healthcare Partners
Seattle, WA
Series A
0No verified founder data yet
BERNIE'S TAKE

Frazier is the grown-up at the healthcare investing table. They've been doing this since 1991 and actually know what they're talking about when it comes to healthcare trends. Their Executive-in-Residence model is legit - they don't just write checks, they pair you with seasoned healthcare operators who've done it before. The Center of Excellence isn't just fancy marketing - it's a real 22-person team providing actual operational support. However, they're institutional money with institutional timelines, so don't expect scrappy startup energy. They want to see proven business models with clear paths to profitability, not moonshot science experiments.

LISTED
CVS Health Ventures
Woonsocket, RI
Series A
0Be the first to add intel
LISTED
Hatteras Venture Partners
Durham, NC
Series A
0Be the first to add intel
LISTED
iGan Partners
Toronto, ON
Series A
0Be the first to add intel
LISTED
Innova Memphis
Memphis, TN
Series A
0Be the first to add intel
LISTED
Intuitive Ventures
Sunnyvale, CA
Series A
0Be the first to add intel
LISTED
Lightstone Ventures
Portola Valley, CA
Series A
0Be the first to add intel
LISTED
Longitude Capital
Menlo Park, CA
Series A
0Be the first to add intel
LISTED
Lumira Ventures
Toronto, ON
Series A
0Be the first to add intel
LISTED
Martin Ventures
Nashville, TN
Series A
0Be the first to add intel
LISTED
Mountain Group Partners
Nashville, TN
Series A
0Be the first to add intel
LISTED
NewSpring Capital
Radnor, PA
Series A
0Be the first to add intel
LISTED
Oak HC/FT
Stamford, CT
Series A
0Be the first to add intel
LISTED
Obvious Ventures
San Francisco, CA
Series A
0Be the first to add intel
LISTED
Quark Venture
Vancouver, BC
Series A
0Be the first to add intel
LISTED
RiverVest Venture Partners
St. Louis, MO
Series A
0Be the first to add intel
LISTED
Samsara BioCapital
Palo Alto, CA
Series A
0Be the first to add intel
LISTED
Santé Ventures
Austin, TX
Series A
0Be the first to add intel
LISTED
Third Rock Ventures
Boston, MA
Series A
0Be the first to add intel
LISTED
Third Rock Ventures
Boston, MA
Series A
0Be the first to add intel
LISTED
Vida Ventures
Los Angeles, CA
Series A
0Be the first to add intel
LISTED
Vine Ventures
New York, NY
Series A
0Be the first to add intel
LISTED
Whitecap Venture Partners
Toronto, ON
Series A
0Be the first to add intel
30 RECORDS — INVESTOR ACCESS PERMANENTLY DENIED
BERNBOOK // FUND INTEL v1